Metabolic bone disease of prematurity screening and individualized enteral mineral supplementation in high-risk neonates: a quality improvement initiative

Priya V. Creed,Katie A. Huff,Kate Beard,Linda A. DiMeglio,Beatrice M. Stefanescu
DOI: https://doi.org/10.1038/s41372-024-01892-9
2024-02-07
Journal of Perinatology
Abstract:Prompted by an alarmingly low screening rate for metabolic bone disease of prematurity (MBDP), we aimed to increase MBDP screening with serum calcium, phosphorous, and alkaline phosphatase at four to six weeks of life in infants born at <1500 g and <32 gestational weeks from a baseline of 27.37% to 90% within one year.
pediatrics,obstetrics & gynecology
What problem does this paper attempt to address?